These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16614113)

  • 21. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of expression of growth differentiation factor 15 in normal and PIN development in the mouse.
    Noorali S; Kurita T; Woolcock B; de Algara TR; Lo M; Paralkar V; Hoodless P; Vielkind J
    Differentiation; 2007 Apr; 75(4):325-36. PubMed ID: 17286605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.
    Cheung PK; Woolcock B; Adomat H; Sutcliffe M; Bainbridge TC; Jones EC; Webber D; Kinahan T; Sadar M; Gleave ME; Vielkind J
    Cancer Res; 2004 Sep; 64(17):5929-33. PubMed ID: 15342369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis.
    Henrique R; Jerónimo C; Teixeira MR; Hoque MO; Carvalho AL; Pais I; Ribeiro FR; Oliveira J; Lopes C; Sidransky D
    Mol Cancer Res; 2006 Jan; 4(1):1-8. PubMed ID: 16446401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein-D: a novel cellular marker for HGPIN and prostate cancer.
    Hall RE; Horsfall DJ; Stahl J; Vivekanandan S; Ricciardelli C; Stapleton AM; Scardino PT; Neufing P; Tilley WD
    Prostate; 2004 Feb; 58(2):103-8. PubMed ID: 14716735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutral endopeptidase protein expression and prognosis in localized prostate cancer.
    Osman I; Yee H; Taneja SS; Levinson B; Zeleniuch-Jacquotte A; Chang C; Nobert C; Nanus DM
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4096-100. PubMed ID: 15217945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry.
    Yang B; Sun H; Lin W; Hou W; Li H; Zhang L; Li F; Gu Y; Song Y; Li Q; Zhang F
    Urol Oncol; 2013 Jul; 31(5):628-34. PubMed ID: 21704537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
    Hu CK; McCall S; Madden J; Huang H; Clough R; Jirtle RL; Anscher MS
    Prostate Cancer Prostatic Dis; 2006; 9(1):62-7. PubMed ID: 16304558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate.
    Patrikainen L; Porvari K; Kurkela R; Hirvikoski P; Soini Y; Vihko P
    Eur J Clin Invest; 2007 Feb; 37(2):126-33. PubMed ID: 17217378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor.
    Lee S; Desai KK; Iczkowski KA; Newcomer RG; Wu KJ; Zhao YG; Tan WW; Roycik MD; Sang QX
    Cell Res; 2006 Sep; 16(9):750-8. PubMed ID: 16940965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct patterns of endothelin axis expression in primary prostate cancer.
    Godara G; Pecher S; Jukic DM; D'Antonio JM; Akhavan A; Nelson JB; Pflug BR
    Urology; 2007 Jul; 70(1):209-15. PubMed ID: 17656249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H; Nonomura N; Nishimura K; Oka D; Shiba M; Nakai Y; Nakayama M; Tsujimura A; Aozasa K; Okuyama A
    BJU Int; 2009 Feb; 103(4):470-4. PubMed ID: 18778349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc-alpha2-glycoprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy.
    Henshall SM; Horvath LG; Quinn DI; Eggleton SA; Grygiel JJ; Stricker PD; Biankin AV; Kench JG; Sutherland RL
    J Natl Cancer Inst; 2006 Oct; 98(19):1420-4. PubMed ID: 17018789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum macrophage inhibitory cytokine-1 concentrations correlate with the presence of prostate cancer bone metastases.
    Selander KS; Brown DA; Sequeiros GB; Hunter M; Desmond R; Parpala T; Risteli J; Breit SN; Jukkola-Vuorinen A
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):532-7. PubMed ID: 17372249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
    Zhou T; Xu C; He M; Sun Y
    Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies.
    Gallo F; Chiono L; Gastaldi E; Venturino E; Giberti C
    Urology; 2008 Sep; 72(3):628-32. PubMed ID: 18279918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-6, IL-10 and HSP-90 expression in tissue microarrays from human prostate cancer assessed by computer-assisted image analysis.
    Cardillo MR; Ippoliti F
    Anticancer Res; 2006; 26(5A):3409-16. PubMed ID: 17094460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.
    Diallo JS; Aldejmah A; Mouhim AF; Péant B; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
    Clin Cancer Res; 2007 Dec; 13(23):7044-52. PubMed ID: 18056181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.